Literature DB >> 6809349

[Efficacy of schistosomicide derivatives, appreciation with electronic microscopy experimental model (author's transl)].

E Forget, H Félix, M J Notteghem, N Léger.   

Abstract

The activity of some schistosomicidal drugs have been studied by electron microscopy on the tegument of Schistosoma mansoni. Results are different and depend of the compound which is tested. Two new compounds: RO 11 3128 and RO 13 3978 are specially active and act in different ways on the tegument. On of them, a benzodiazepine, have been tested in association with an "antibenzodiazepine" compound in order to avoid the sedative action without decrease of the schistosomicidal activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809349

Source DB:  PubMed          Journal:  Bull Soc Pathol Exot Filiales


  4 in total

1.  Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978.

Authors:  Chunkai Wang; Qingjie Zhao; Jaeki Min; Sakthivel Muniyan; Mireille Vargas; Xiaofang Wang; Yuxiang Dong; R Kiplin Guy; Ming-Fong Lin; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  Am J Trop Med Hyg       Date:  2014-03-31       Impact factor: 2.345

Review 2.  Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?

Authors:  Godwin Akpeko Dziwornu; Henrietta Dede Attram; Samuel Gachuhi; Kelly Chibale
Journal:  RSC Med Chem       Date:  2020-04-06

3.  Molecular cloning and characterization of novel glutamate-gated chloride channel subunits from Schistosoma mansoni.

Authors:  Vanessa Dufour; Robin N Beech; Claudia Wever; Joseph A Dent; Timothy G Geary
Journal:  PLoS Pathog       Date:  2013-08-29       Impact factor: 6.823

4.  Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978).

Authors:  Chunkai Wang; Qingjie Zhao; Mireille Vargas; Jeremy O Jones; Karen L White; David M Shackleford; Gong Chen; Jessica Saunders; Alice C F Ng; Francis C K Chiu; Yuxiang Dong; Susan A Charman; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  J Med Chem       Date:  2016-11-28       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.